HomeREGULATORY
REGULATORY

CSIMC Recommends NHI Price Listing for 15 APIs/20 Products
(Sep.7.2011)

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story

Commentary

Industry Faces Tough Road to Institutionalization of Key Premium, Eligibility Up for Discussion

Lexicon

Japan Medical Association (JMA):
日本医師会

The Column

Emerging Immunotherapy of Cancer: 2

Archives

Chuikyo Subcommittee OKs Point-Based Premium Calculation Method, Adoption Scheduled in May (Apr.24)
LDP Study Group to Call for Expansion of R&D Tax Credit System, Oppose Annual NHI Price Cuts (Apr.24)
MTPC Names Masayuki Mitsuka as New President (Apr.24)
JPMA Announces New Guidelines on Support for Clinical Research (Apr.24)
Yoshindo, Lupin to Establish JV to Develop Etanercept Biosimilar, Start Clinical Trial in FY2014 (Apr.24)

Most Read

1.
Sanofi Aims to ...
2.
New Health Mini...
3.
Entry into Japa...
3.
DPJ Member Naga...
5.
Govt Deregulati...

News Calendar